Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Immunosuppressants - Indonesia

Indonesia
  • The Immunosuppressants market in Indonesia is expected to witness significant growth in the coming years.
  • According to projections, the revenue is set to reach US$108.60m in 2024.
  • Furthermore, it is anticipated that the market will experience a steady annual growth rate of 15.80% from 2024 to 2029.
  • This growth trajectory is expected to contribute to a substantial market volume of US$226.20m by 2029.
  • In terms of global comparison, United States is projected to generate the highest revenue in the Immunosuppressants market, with an estimated value of US$35.47bn in 2024.
  • This underscores the dominant position of the United States in this market.
  • Indonesia's immunosuppressant market is witnessing a surge in demand due to the increasing prevalence of autoimmune diseases in the country.

Definition:
The Immunosuppressants market covers drugs which suppress the immune response. These remedies are used in different therapy areas, mainly to treat auto-immune diseases, such as psoriasis. Anti-rejection drugs administered after organ transplantations are also included in this market. Monoclonal antibodies are an important type of immunosuppressant.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Johnson & Johnson, Sanofi, Novartis

In-Scope

  • Drugs to suppress the immune response
  • Immunosuppressants to treat auto-immune diseases, such as psoriasis
  • Anti-rejection drugs

Out-Of-Scope

  • Multiple sclerosis drugs
  • Anti-rheumatic drugs
  • Immuno-oncology drugs
  • Antivirals
  • Antibiotics
  • Corticosteroids
  • HIV drugs
Immunosuppressants: market data & analysis - Cover

Market Insights report

Immunosuppressants: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Immunosuppressants market in Indonesia has experienced significant growth in recent years.

    Customer preferences:
    There has been an increase in demand for Immunosuppressants in Indonesia due to the rising incidence of autoimmune diseases and organ transplants. Patients suffering from autoimmune diseases such as rheumatoid arthritis, lupus, and multiple sclerosis require Immunosuppressants to suppress their immune system. Additionally, the increasing number of organ transplants in the country has also contributed to the growth of the market.

    Trends in the market:
    The Immunosuppressants market in Indonesia has been growing steadily due to the increasing prevalence of autoimmune diseases and organ transplants. The market is expected to continue to grow as the population ages and the incidence of autoimmune diseases increases. Furthermore, the government's efforts to improve healthcare infrastructure and increase access to healthcare services have also contributed to the growth of the market.

    Local special circumstances:
    Indonesia is the fourth most populous country in the world, with a population of over 270 million people. The country has a large and growing middle class, which has led to an increase in demand for healthcare services. However, the healthcare infrastructure in the country is still developing, and access to healthcare services is limited in some areas. This has created opportunities for pharmaceutical companies to expand their presence in the country.

    Underlying macroeconomic factors:
    Indonesia's economy has been growing steadily in recent years, with a GDP growth rate of around 5% per year. The country's healthcare sector has also been growing, with the government increasing its healthcare spending in recent years. The government's efforts to improve healthcare infrastructure and increase access to healthcare services have created opportunities for pharmaceutical companies to expand their presence in the country. Furthermore, the increasing prevalence of autoimmune diseases and organ transplants has also contributed to the growth of the Immunosuppressants market in Indonesia.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Immunosuppressants: market data & analysis - BackgroundImmunosuppressants: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.